Aims: The Na,K-ATPase is involved in a large number of regulatory activities including cSrc-dependent signalling. Upon inhibition of the Na,K-ATPase with ouabain, cSrc activation is shown to occur in many cell types. This study tests the hypothesis that acute potentiation of agonist-induced contraction by ouabain is mediated through Na,K-ATPase-cSrc signalling-dependent sensitization of vascular smooth muscle cells to Ca 
regulatory function(s), although this subdivision is artificial and to a large extent depends on the cell type. 2 Many of these functions are shown to be associated with [Ca 2+ ] i signalling controlled by a signalosome in the cell membrane, where the Na,K-ATPase interacts with other transport proteins important for Ca 2+ homeostasis, such as the Na,Ca-exchanger. 3, 4 These signalosomes include projection(s) of the sarcoplasmic reticulum (SR), which facilitate local Ca 2+ transients in a restricted submembranous space, upon pharmacological suppression of Na,K-ATPase ion-pumping activity. This localized [Ca 2+ ] i augments Ca 2+ uptake into the SR and initiates several Ca
2+
-dependent signalling pathways.
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This mechanism provides a potential explanation for the pro-contractile action of ouabain. Indeed, submicromolar concentrations of ouabain acutely potentiate myogenic tone 6, 7 and agonist-induced contraction 8, 9 of small arteries, with these effects being potentially important for the prohypertensive action of ouabain. [10] [11] [12] However, several observations suggest that this might not be the only mechanism responsible for the contractile action of ouabain. Micromolar ouabain does not affect global VSMC [Ca 2+ ] i and [Na + ] i , while contraction is increased. 8, 13 Moreover, in contrast to ouabain, another Na,K-ATPase inhibitor, digoxin, does not raise blood pressure and even has antihypertensive action in ouabain-dependent hypertension models. 14, 15 Furthermore, transient downregulation of the Na,K-ATPase a2 isoform suppresses contraction in small arteries instead of, as expected from pharmacological studies, having a contractile effect. 9 These observations indicate that the mechanism responsible for the change in vascular tone following inhibition of the Na,K-ATPase requires clarification. In addition to modulating ion concentrations, per above, the Na,K-ATPase has been suggested to be in a membrane microdomain with several proteins involved in intracellular signalling pathways including cSrc kinase. 16 This hypothesis is supported by the well-established activation of cSrc by phosphorylation at Y418 in response to ouabain. [17] [18] [19] [20] [21] [22] [23] The Na,K-ATPase N-terminus has been suggested to interact physically with cSrc 23 and mutation in this domain disturbs cSrc signalling without affecting ion pumping. 21 Vice versa, a non-pumping Na,K-ATPase with intact N-terminus initiates cSrc signalling, 24 while Na,K-ATPase knockdown antagonizes ouabain-induced signalling. 9 This model of cSrc activation by ouabain is not consistent with studies suggesting a key role for changes in ATP consumption by the Na,K-ATPase for cSrc autophosphorylation. [25] [26] [27] Although interference with Na,K-pump activity does not affect the global ATP concentration in VSMCs, 28 local restricted changes in the ATP/ADP ratio might occur. 29 Accordingly, submicromolar and micromolar concentrations of ouabain do not affect the global ATP/ADP ratio in skeletal muscles, but activate cSrc kinase. 30 The Na,KATPase-cSrc microdomain hypothesis is also supported by an interaction between the Na,K-ATPase with Src-associated phosphoprotein. 31 Moreover, a peptide composed of the Na, K-ATPase N-terminal amino acid sequence suggested to be involved in the interaction with cSrc 23 is shown to inhibit the Na,K-ATPase-dependent cSrc activation in several cell culture systems 21, 32 and in tumour xenografts in vivo. 33 The importance of this cSrc activation is shown in epithelial cells, 34 neurons 35 and tumour cells, 33 but has not been fully clarified in the vasculature. Recently, acute ouabain application has been shown to modulate intercellular communication(s) in the vascular wall via cSrc-dependent pathway(s). 36 This is consistent with previous reports that cSrc activity is relatively high in VSMCs 37 and that chronic (days to weeks) ouabain treatment activates vascular cSrc, although it is unknown whether chronic cSrc activation is important for arterial contraction. 15 In contrast, blockade of the Na,KATPase with digoxin did not activate cSrc in the vascular wall, 15 suggesting a potential mechanism for previously reported ouabain-digoxin antagonism on arterial contraction and blood pressure. 14, 38 The importance of tyrosine phosphorylation for mesenteric artery contraction was suggested previously. 37 It has been shown that the cSrc kinase can activate Rho-associated protein kinase to increase the Ca 2+ sensitivity of the VSMC contractile machinery. 39 However, whether ouabain induces potentiation of agonist-induced contraction through the Na,K-ATPase-cSrc signalling pathway with consequent VSMC sensitization to Ca 2+ requires experimental testing. This study tested the hypothesis that the Na,K-ATPasecSrc signalling pathway contributes to the acute potentiation of agonist-induced contraction by ouabain. The hypothesis that activation of tyrosine phosphorylation by ouabain potentiates vasoconstriction by modifying the sensitization of the contractile apparatus to Ca 2+ via myosin phosphatase targeting protein 1 (MYPT1) phosphorylation was also examined.
| RESULTS

| Tyrosine kinase-dependent potentiation of agonist-induced contraction by ouabain
Ten micromolar ouabain, applied 15 minutes prior to noradrenaline (NA) stimulation, significantly potentiated contraction of rat mesenteric small arteries in comparison with responses of the same artery under control conditions (Figures 1A-C and S1A-C). In the presence of genistein, ouabain failed to potentiate arterial contraction ( Figures 1A  and S1A ). In the presence of vehicle (DMSO), ouabain still potentiated the response to NA ( Figures 1B and S1B ). The tyrosine kinase inhibitor, PP2, abolished the potentiating effect of ouabain on arterial contraction ( Figures 1B and  S1B ). An inactive analogue of PP2, PP3 was without effect on ouabain-induced potentiation of contraction (Figure S2) . A peptide inhibiting the Na,K-ATPase-dependent cSrc kinase activation, 23, 33 pNaKtide prevented the potentiating effect of ouabain on NA-induced contraction (Figures 1C and S1C). In contrast to ouabain, another inhibitor of the Na,K-ATPase, digoxin, was without effect on NAinduced contraction both under control conditions and in the presence of pNaKtide ( Figures 1D and S1D ).
| Tyrosine kinase-dependent potentiation of contraction by ouabain is not endotheliumdependent
Ouabain potentiated NA-induced contraction of endothelium-denuded mesenteric arteries (Figures S3A-C and S4A-C) in a similar manner to the effect seen in endothelium-intact arteries (Figures 1A-C and S1A-C). Genistein, PP2 and pNaKtide prevented ouabain-induced potentiation of contraction in endothelium-denuded arteries (Figures S3A-C and S4A-C). Contraction of endothelium-denuded arteries was not affected by pNaKtide alone, suggesting that suppression of the contraction in endothelium-intact arteries by pNaKtide ( Figure 1C ) did, at least in part, depend on endothelium. This might be due to an antagonizing effect of pNaKtide on tyrosine phosphorylation of endothelium NO synthase that inhibits enzyme activity. 40, 41 However, this study focussed on tyrosine kinase-dependent pro-contractile action of ouabain in smooth muscle cells.
| Ca
2+ sensitization induced by ouabain is abolished by inhibition of tyrosine kinase
The ratio of fluorescence during excitation at 340 nm and 380 nm from Fura-2 fluorophore loaded arterial segment was used to estimate the relative changes in [Ca 2+ ] i . Simultaneous measurement of vascular tone and the relative F I G U R E 1 Inhibition of tyrosine kinase prevents potentiation of contraction by ouabain. Area under curve comparison for these concentration-response curves is shown in Figure S1 . Ouabain (10 lmol L
À1
) potentiated NA-induced contraction, but in the presence of 30 lmol L À1 genistein, ouabain did not affect contraction (A; n = 5-6). Ouabain also potentiated NA-induced contraction in the presence of
) prevented the potentiation of contraction by ouabain (B; n = 7-8). Potentiation of contraction by ouabain (C) was not seen in the presence of pNaKtide (C; n = 8). Digoxin (10 lmol L
) had no effect on NA-induced contraction under control conditions and in the presence of pNaKtide (2 lmol L À1 ) (D; n = 5). Stimulation of an artery under control conditions was repeated in the presence of ouabain or an inhibitor (genistein or PP2 or pNaKtide) and then repeated in the presence of both ouabain and genistein. The concentration-response curves were compared with the extra sum-of-squares F test. *P < .05 and †P < .01 changes in [Ca 2+ ] i indicated that the potentiation of contraction by ouabain is not associated with a significant increase in [Ca 2+ ] i (Figure 2A, ] i was inhibited by pNaKtide (Figure 2 ). Sensitivity to [Ca 2+ ] i was similar under control conditions, in the presence of pNaKtide alone and in the presence of both pNaKtide and ouabain. A similar suppression of ouabain-induced Ca 2+ sensitization was seen with genistein (data not shown).
| Ouabain-induced autophosphorylation of cSrc correlates with MYPT1 phosphorylation
NA-induced contraction is known to sensitize the contractile machinery of VSMCs to Ca 2+ via RhoA kinase-dependent inhibition of myosin light chain phosphatase. This is mediated via phosphorylation of MYPT1. MYPT1 phosphorylation at T850 in mesenteric arteries in the presence of 10 lmol L À1 NA was significantly increased ( Figure 3A ,B).
NA-induced MYPT1 phosphorylation was further increased in the presence of 10 lmol L À1 ouabain. Accordingly, 10 lmol L
À1
ouabain significantly potentiated the contraction to a bolus 10 lmol L À1 NA application by 11.9 AE 3.1% from the control response (n = 6; P < .001). This ouabain-induced increase was antagonized by pNaKtide, although both pNaKtide and ouabain alone had no significant effect on the NA-induced MYPT1 phosphorylation ( Figure 3B ). Tyrosine autophosphorylation at Y418 is essential for cSrc activation, 42 has been shown to be potentiated in the vascular wall by ouabain 15, 36 and confirmed here (Figure 3B,D) . Moreover, this ouabain-induced cSrc activation in rat mesenteric arteries was antagonized by pNaKtide. 36 In this study, we found that NA also increased phosphorylation of cSrc and this was further increased by ouabain (Figure 3C,D) . Importantly, the effects of ouabain and NA on cSrc phosphorylation were additive, and pNaKtide did not significantly affect cSrc activation (and MYPT1 phosphorylation) by NA.
| Effect of ouabain on vascular function in vivo
The effect of ouabain and pNaKtide on responses to EFS was tested in vivo in anaesthetized rats ( Figure 4A ). Ouabain significantly increased mesenteric artery tone in vivo prior to EFS ( Figure 4B ). Electric field stimulation induced a frequency-dependent decrease in arterial diameter ( Figure 4A ); incubation with ouabain potentiated contraction to intermittent stimuli (4 and 8 Hz; Figure 4C ), but was without effect at higher frequencies (16 and 32 Hz; data not shown; (from data shown in A). Linear regression analysis indicates significant (P < .05) difference between changes under control conditions and in the presence of ouabain, as well as between responses in the presence of ouabain and a combination of ouabain and pNaKtide (P < .05), or pNaKtide alone (P < .05). No difference between control responses and responses in the presence of pNaKtide alone or both pNaKtide and ouabain was seen. *P < .05, †P < .01 and ‡P < .001 n = 7). The effect of ouabain was inhibited by pNaKtide; pNaKtide alone was without effect on EFS responses in vivo ( Figure 4C ).
| Downregulation of the Na,K-ATPase a2 isoform prevents the contractile effect of ouabain
Whole-mount immunohistochemical staining identified expression of both a1 and a2 Na,K-ATPases in the arterial wall (Figure 5A ). Rat mesenteric arteries were transfected in vivo with siRNA directed against either the Na,K-ATPase a1 or a2 isoform. Three days after transfection, a significant mRNA downregulation of the targeted isoform of the Na,K-ATPase was detected (
Figure 5B,C). Transfection with siRNA against the a1 isoform Na,K-ATPase significantly reduced expression of this isoform. However, expression of the a2 isoform was also suppressed, making a functional signal discernment with this approach not viable ( Figure 5B ). In contrast, downregulation of the a2 isoform Na,K-ATPase with the a2 isoform-directed siRNA was without significant effect on a1 isoform expression ( Figure 5C -E). This is consistent with previous data. ), in the presence of NA, ouabain and pNaKtide and in the presence of ouabain alone, as indicated. In representative blots (A, C), the vertical white space between the bands indicates that irrelevant lane(s) from the same film are not shown. Phosphorylated protein (phospho-MYPT or phospho-cSrc) was normalized to total (MYPT1 or cSrc) detected for the corresponding lysate. An averaged normalized phosphorylated protein under control conditions was taken as 100% and used as a reference to semiquantify the individual responses to interventions. *P < .05; †P < .01 and ‡P < .001
This downregulation of the Na,K-ATPase a2 isoform was subsequently used in functional studies. Ouabain significantly potentiated, while pNaKtide inhibited, NAinduced contraction of arteries transfected with non-related siRNA ( Figure 5F ). When the a2 isoform Na,K-ATPase was downregulated, no effect of ouabain and pNaKtide was seen ( Figure 5F ).
| DISCUSSION
The present data show that ouabain-induced potentiation of arterial contraction is mediated via the Na,K-ATPase a2 isoform-cSrc signalling pathways both in vitro and in vivo. Furthermore, the ouabain-induced cSrc-associated potentiation of contraction is shown to be mediated via sensitization of VSMC contractile machinery to Ca 2+ ( Figure 6 ).
| Ouabain-induced potentiation of contraction occurs without elevation of [Ca 2+ ] i
Ouabain and digoxin inhibit the pumping activity of the Na,K-ATPase with similar potency, but have different effects on rat mesenteric arterial contraction.
14 Accordingly, the current study showed that an acute application of ouabain, but not digoxin, potentiated agonist-induced contraction of rat mesenteric small arteries. The potentiating effect of ouabain could be due to inhibition of an electrogenic ion-pumping activity of the Na,K-ATPase. ] i in response to agonist stimulation. 13, 44 Furthermore,
) potentiated basal tone and responses to electrical field stimulation (EFS) of rat mesenteric arteries in vivo while pNaKtide (2 lmol L À1 ) antagonized this effect. Representative traces of arterial response to different frequency EFS under control conditions and after incubation with ouabain (A). Resting inner diameter (ie, prior to EFS stimulation as indicated by blue "B" in A) under control conditions, in the presence of ouabain, in the presence of pNaKtide and in the presence of both ouabain and pNaKtide is shown in B. *P < .05 (paired t test; the effect of each treatment is compared to corresponding control conditions). The responses to different frequency EFS (as indicated by red "C" in A) under control conditions and in the presence of either ouabain (n = 7) or pNaKtide (n = 7) or both (n = 6) were compared (C). ‡P < .001, (repeated measures two-way ANOVA) 10 lmol L À1 ouabain only caused a~3 mV depolarization of VSMC resting membrane potential 36 and has no effect on resting vascular tone of rat mesenteric small arteries in vitro. 9 The potentiation of contraction by ouabain has been hypothesized to be a result of spatially restricted signalling in the membrane microdomain. It has been suggested that an elevation of submembrane Na + upon Na,K-ATPase inhi- tone by ouabain has been suggested to be due to both enhanced spontaneous NA release from perivascular sympathetic nerves and direct effects on smooth muscle. 47 Accordingly, in the current study, ouabain potentiated myogenic tone in vivo seen as a decrease in resting arterial diameter, although no significant potentiation of [Ca 2+ ] i changes in response to agonist stimulation in vitro was found.
F I G U R E 5 Downregulation of the Na,K-ATPase a2 isoform prevents the effects of ouabain and pNaKtide on arterial contraction.
Mesenteric small artery whole-mount staining shows the expression of a1 and a2 isoforms of the Na,K-ATPase (A; n = 4), with insets showing cell patency via propidium iodide label (upper), secondary only (a1) and peptide block (a2; lower). Arteries were transfected with either nonrelated siRNA or with siRNA directed against the a1 (B; n = 8) or a2 isoform (C; n = 6). mRNA expression was semiquantified with QPCR in relation to the level in non-transfected arterial branches from the same rat taken as 100% (B, C). Representative Western blots for the a1 and a2 isoforms and pan-actin expression in the arterial segments transfected with siRNA directed against the a2 isoform (D). Averaged semiquantification results of the experiments shown in D (E; n = 5); the expression under control conditions are taken as 100%. No significant difference in intensities for pan-actin staining was seen between non-transfected controls (taken as a 100%), a2-siRNA (105.5 AE 4.1%) and nonrelated siRNA groups blotted for a1 Na,K-ATPase (103.6 AE 9.9%), a2-siRNA (121.3 AE 24.1%) and non-related siRNA groups blotted for a2 Na,K-ATPase (109.1 AE 20.5%; n = 5). Concentration-response curves for arteries under control conditions and in the presence of either ouabain (10 lmol L The Na,K-ATPase has been suggested to be a key part of a cell membrane signalosome, which integrates several pathways and related protein activities, including cSrc kinase. 16 This hypothesis is supported by the well-established activation of cSrc by phosphorylation at Y418 in response to ouabain in different non-vascular cell types, [17] [18] [19] [20] [21] [22] [23] phosphorylation. This is in line with a previous report showing that orthovanadate constricts rat mesenteric arteries via cSrc activation that mediates Rho kinase-associated MYPT1 phosphorylation, 48 and several other reports suggesting that cSrc signalling is upstream of Rho kinase activation. 49 The present study showed that three structurally different inhibitors that interfere with tyrosine phosphorylation, that is genistein, PP2 and pNaKtide, antagonize the pro-contractile effect of ouabain. This was further supported by data showing the ouabain-dependent cSrc, and MYPT1 phosphorylations were inhibited by pNaKtide. In canine pulmonary arteries, inhibition of tyrosine kinase is shown to attenuate Ca 2+ sensitization upon phenylephrine stimulation, 50 but this pathway has only a modulatory effect on Rho-dependent Ca 2+ sensitization. 39 In the current study, ouabain also potentiated the effect on Rho kinaseassociated MYPT1 phosphorylation in response to NA stimulation. This pathway is thus suggested to underlie the ouabain-induced Ca 2+ sensitization and potentiation of agonist-induced contraction ( Figure 6 ). Importantly, in the present study, both NA and ouabain induced cSrc phosphorylation, but their effects were additive. Moreover, pNaKtide inhibited only ouabain-induced cSrc phosphorylation, suggesting an interference only with the Na,KATPase/cSrc pathway; thus, also suggesting that NA does not directly activate this pathway, but rather the NAinduced contraction can be modulated through it. This is further supported by pNaKtide not having an effect on NA-dependent MYPT1 phosphorylation and that ouabain alone did not increase MYPT1 phosphorylation. Structurally unrelated tyrosine kinase inhibitors abolish myogenic tone in pressurized rat cremaster arterioles in vitro, while inhibition of tyrosine phosphatase potentiates myogenic tone. 51 In fact, an elevation in wall tension was previously shown to cause an increased tyrosine phosphorylation, but this was suggested to be involved only in generation of sustained myogenic tone without any significant implication in acute myogenic contraction. 52, 53 In the current study, pNaKtide abolished ouabain-induced sustained (>15 minutes after ouabain application) myogenic tone in rat mesenteric artery in vivo, which is consistent with the suggestion that tyrosine kinase activity might be important for modulating myogenic tone. ] i , seen in the current study in the presence of tyrosine kinase inhibitors, could be a result of suppressed tyrosine phosphorylation of voltage-gated Ca 2+ channels. However, this observation may also be an effect of membrane hyperpolarization due to activation of voltage-gated and Ca 2+ -activated K + channels. 57 Accordingly, 
F I G U R E 6
| Endothelium-independent cSrcassociated potentiation of contraction by ouabain
Vascular endothelial cells also express the Src kinase family. The Src kinase regulates several endothelial cell functions including NO synthase (eNOS) activity. 58 The effect of tyrosine kinase phosphorylation was reported to have both inhibitory 40, 41 and stimulatory 59 effects on eNOS. The present findings that pNaKtide suppressed arterial contraction in an endothelium-dependent manner suggest that an endothelial Na,K-ATPase-cSrc pathway inhibits release of endotheliumderived relaxing factor(s). This could be mediated through tyrosine phosphorylation and inhibition of eNOS 40, 41 and thus further contribute to the pro-contractile effect of ouabain, which might activate endothelial cell cSrc. This pNaKtide-induced release of endothelium-derived relaxing factor (s) could contribute to the decrease in [Ca 2+ ] i seen in the presence of tyrosine kinase inhibitors, although this remains to be verified. The current study focus is on ouabain-induced potentiation of VSMC contraction and suggests that the main Na,K-ATPase-cSrc-MYPT1 signalling occurs in VSMCs. This is in accordance with a recent report showing that the importance of Src kinase in agonist-induced contraction is primarily mediated via VSMC Src. 
| cSrc signalling is mediated via the Na, K-ATPase a2 isoform
In the current study, downregulation of the Na,K-ATPase a1 isoform was associated with a significant reduction in the Na,K-ATPase a2 isoform at the mRNA level. This is surprising as knockdown of the vascular a1 isoform in genetically modified mice was shown to slightly potentiate the expression of the a2 isoform, although it did not compensate for a total reduction in the Na,K-ATPase protein. 7 On the other hand, a significant and transient reduction in the housekeeping a1 isoform could have a suppressive effect on the expression profile in general. Downregulation of the Na,K-ATPase a2 isoform was without any significant effect on the a1 isoform expression. This is in accordance with previous reports from genetically modified mice 6 and siRNA-induced downregulation. Downregulation of the a2 isoform demonstrated a key role of this isoform in Na,K-ATPase-dependent cSrc signalling in VSMCs and arterial contractility. This is consistent with the apparent importance of the a2 isoform for ouabain-dependent potentiation of contraction. 7, 9, 12, 13, 46 However, the functional effects of changes in the expression of the a2 isoform differ between studies. 7, 9, 12 Thus, reduced expression of the a2 isoform in genetically modified mice potentiated myogenic tone consistent with the effect of pharmacological inhibition of the Na,K-ATPase by ouabain. 12, 45 Moreover, increased agonist-induced contraction in aorta from a2 isoform knockout mice has been reported. 7 However, this was not the case for transient siRNA-induced downregulation of the a2 isoform in rat mesenteric arteries, which surprisingly led to reduced arterial contraction. 9 This was associated with reduced expression of the Na,Ca-exchanger consistent with other observations where expression of the Na,Ca-exchanger changes with the expression level of the Na,K-ATPase a2 isoform in aortic 4 and mesenteric artery smooth muscle cells. 6, 15 Notably, it remains unclear whether and how the Na,K-ATPase may modulate Na,Ca-exchanger expression, although mediation via cSrc signalling has been suggested. 15 Importantly, in the current study, contraction of arteries downregulated for the Na,K-ATPase a2 isoform was insensitive to ouabain and pNaKtide. This suggests that downregulation abolished Na,K-ATPase-dependent cSrc signalling. Unfortunately, the present work was unable to measure cSrc phosphorylation in siRNA-transfected arteries, due to the small vessel segment size and mass. A role for the Na,K-ATPase a2 isoform in ouabaininduced cSrc signalling in the vascular wall does not support by previous studies. In kidney and ovarian-derived cell lines, a distinct role for the a1 isoform in this type of signalling is suggested. 21, 32 It has been previously shown in cultured kidney epithelial cells that the Na,K-ATPase a1 isoform preferentially inhibits Src kinase in its E1 conformation. 18 As the E1/E2 conformation equilibrium is determined, among other factors, by cytosolic concentration of Na + , 60 it can be hypothesized that localized changes in Na + upon the a2 isoform inhibition can activate cSrc from the Na,K-ATPase a1 isoform. However, previous studies on a human skeletal muscle cell line show an interaction of both the a1 and a2 Na,K-ATPase isoforms with cSrc kinase. 30 The reason for this inconsistency is puzzling and could be due to differences between expression systems and native cells. In fact, the often used epithelial cell expression systems express only the a1 isoform Na,KATPase, while skeletal and VSMCs have substantial expression of both a1 and a2 isoforms. 2 Thus, in native cells, the Na,K-ATPase-dependent cSrc signalling might be defined by microdomain environment and/or other intrinsic phenotypic properties and differences. Moreover, a cross-talk between the conventional model for Na,Ca-exchangerdependent Ca 2+ clearance and the Src signalling pathway has been suggested; although further studies are required to clarify this issue.
14,15,32
| PERSPECTIVES
Circulating endogenous ouabain is a key component of a novel hormonal system produced by the adrenals and in the hypothalamus. 38 Although the mechanism of its action remains unknown, it is associated with hypertension. 61 Abnormally elevated plasma ouabain is detected in~50% of patients with essential hypertension and correlates with blood pressure 62 and with cardiac 63 and kidney 64 damage.
One of the key pro-hypertensive actions of endogenous ouabain is the elevation of vascular tone and peripheral resistance. 65 While the detailed mechanism of this potentiation remains to be elucidated, it has been suggested to be due to an increased contractility of small arteries. 43 However, the mechanism behind this remains controversial. In the current study, data demonstrate that acute potentiation of agonist-induced contraction by ouabain might be a product of the Na,K-ATPase-modulated cSrc activity in VSMCs. The present study shows an important role of the Na,K-ATPase a2 isoform in the initiation of this cSrc signalling pathway. Specific inhibition of Na,K-ATPasedependent cSrc signalling may be beneficial in normalizing vascular resistance and tissue perfusion.
| MATERIALS AND METHODS
All experiments conformed to guidelines from the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes and were approved by and conducted with permission from the Animal Experiments Inspectorate of the Danish Ministry of Environment and Food.
| Isometric force measurement of isolated arteries
Male Wistar Hannover rats, 11-12 weeks of age, were obtained from Janvier laboratories (France) and killed with CO 2 inhalation. Third-order branches of the mesenteric artery were mounted in an isometric myograph (Danish Myo Technology A/S, Denmark) and stretched to obtain maximal active force. 66 Force (mN) was recorded with a PowerLab 4/ 25-Chart7 acquisition system (ADInstruments, New Zealand) and converted to wall tension. 9, 67 In experiments with endothelium-denuded arteries, the endothelium was removed by gently rubbing the luminal surface with a hair. Successful removal was confirmed by the lack of relaxation to 10 lmol L À1 acetylcholine. The repeated concentrationresponse curves were obtained from the same artery; first, under control conditions, then, the second concentrationresponse curve after pre-incubation with a single drug (ouabain or digoxin or tyrosine kinase inhibitor) and the last curve after pre-incubation with a combination of drugs (ouabain or digoxin and tyrosine kinase inhibitor). In the time-control experiments, there was no difference in concentration-response curves obtained in three consecutive agonist stimulations of the same artery (not shown). ] i measurements were obtained simultaneously with isometric force from arterial segments loaded with 2.5 lM Fura-2-acetoxymethyl ester (Fura-2-AM). 9 Arteries were excited alternately at 340 and 380 nm, and emitted light was measured at 515 nm using Felix32 software (ver.1.2, Photon Technology, USA). Background fluorescence (at the end of experiment, the arterial segment was permeabilized with 8 lM ionomycin and the fluorescence quenched with 20 mmol L À1 of MnCl 2 ) was determined and subtracted. 9 The relative changes in [Ca 2+ ] i were expressed as the ratio of fluorescence during excitation at 340 and 380 nm.
|
| Functional studies on rat mesenteric small arteries in vivo
The functional responses of rat mesenteric arteries in vivo were assessed as described previously. 68 In brief, rats were anesthetized (s.c.) with ketamine (33 mg/100 g; Ketaminol â vet, Intervet International, Holland) and xylazine (7.5 mg/100 g; Narcoxyl â vet, Intervet International, Holland). A lateral laparotomy was performed on a thermostatic platform at 37°C, and a short segment (1.5-2 cm) of the intestine and mesentery was carefully pulled out. A single branch of the mesenteric artery was placed in a small reservoir (volume~100 lL) by passing ends of the branch through openings at two sides of the reservoir and sealing with high vacuum grease (Dow Corning GMBH, Wiesbaden, Germany). The arterial segment in the reservoir was cleaned of fat. The reservoir was filled with in ice-cold salt solution (PSS) containing 10 mmol L À1 HEPES in PSS bubbled with 5% CO 2 in N 2 (to achieve low O 2 tension similar to conditions in tissue in vivo) and covered with Parafilm to reduce evaporation. During the experiment, the extracted intestine and mesentery were kept moist using bandages soaked in HEPES-PSS. The inner diameter of the artery was captured with a USB CCD Monochrome Camera (DMK 41AU02, Imaging Source, Germany) attached to the microscope (Motic PSM-1000, China) and processed using DMT Vessel Acquisition Suite software (Danish Myo Technology A/S, Denmark). The inner diameter was recorded at rest and during electric field stimulation (EFS) at 2-8 Hz (pulse width 1.5 ms, current 15 mA in trains of 10 seconds duration; the platinum electrodes located in the reservoir on the sides of the artery).
| Semiquantification of protein phosphorylation by Western blot
Mesenteric arteries were fixed in ice-cold 10 mmol L 10 minutes at 95°C, ultrasonicated for 45 seconds and centrifuged at 10 000 g. It was not possible to detect the protein concentration in lysate. 36 Ten and five micro litre of the supernatant were loaded on 4-15% trisglycine gels for identification of phosphorylated and total proteins respectively. Nitrocellulose membranes were blocked in 3% bovine serum albumin (BSA) in Tris-buffered solution (TBS, mmol L À1 : 10 Tris-HCl, 100 NaCl; pH 7.6) with 0.5% vol vol À1 tween 20 (TBST) or in 0.3% iBlock in TBS, when membranes were used to identify phosphorylated and total proteins respectively. Membranes were divided at 100 kDa, 50 kDa and 35 kDa for MYPT (expected band~130 kDa), cSrc (expected band~65 kDa) and thioredoxin 2 (expected band~12 kDa) detections. Thioredoxin 2 used as a loading control. 36 The membranes were incubated with well-characterized primary antibodies overnight at 4°C. The membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000; Dako, Denmark), and bound antibodies were detected by an enhanced chemiluminescence kit (ECL, Amersham, UK). 9 Intensities of detected bands of expected molecular weights were measured using ImageJ software (NIH, USA). Protein phosphorylation was semiquantified as a ratio between intensities of phosphoprotein (pMYPT or p-cSrc) and total protein (MYPT or cSrc). The average control (ie, in the absence of drugs) was set to 100% to compare intervention effects. ) following incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (1 : 4000; Dako, Denmark) for enhanced chemiluminescence detection (ECL, Amersham, UK) of bound antibody. Membranes were then stripped for antibodies and stained for pan-actin (Cell Signaling Technology, USA [Catalog no. 4968]). ImageJ program (NIH, USA) was used for protein semiquantification as a ratio to pan-actin measured in the same probe.
The RNA isolation was carried out as described previously. 9 Primer sets for quantitative PCR analyses of the a1 and a2 isoforms of the Na,K-ATPase, peptidylprolyl isomerase A (pPia) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression were obtained from Applied Biosystems (Thermo Fisher Scientific, Denmark). Quantitative PCR was carried out on MX3000P (Stratagene, USA) using TaqMan probe (FAM) technology. Similar distances between Ct values for GAPDH and pPia genes in different experimental groups suggested that their expression was not affected by transfection (not shown). Averaged Ct value for GAPDH and pPia was used to normalize gene expression as a DC t value. Normalized gene expression of non-transfected control and transfected arteries was compared by subtraction of DCt for the control group from transfected DCt value, producing DDC t . Thus, relative gene expression was standardized to non-transfected control arteries from the same rat and calculated as 1/(2 DDC t ). purity >95%) was prepared in water (0.01 mol L À1 ), divided into aliquots and stored at À20°C. All other chemicals were purchased from Sigma-Aldrich (Denmark). Stock solutions of genistein and PP2 were prepared in DMSO (0.01 mol L À1 ), divided into aliquots and stored at À20°C.
Ouabain stock solutions were prepared on the day of experiment (minimum 2 hours prior to application) in a concentration of 0.01 mol L À1 in water. Drugs were applied a minimum 15 minutes prior to measurements/interventions.
| Data analysis
Graphing and statistical analysis were performed using GraphPad Prism software (v.5.02 for Windows). All data are presented as mean values AE SEM. Concentrationresponse curves were fitted to experimental data using four-parameter, nonlinear regression curve fitting. From these curves, pD 2 (ÀlogEC 50 , where EC 50 is the concentration required to produce a half-maximal response) and maximal response were derived and compared using an extra sum-of-squares F test. Differences between means were tested by one-way ANOVA followed by Bonferroni post-test (eg, Western blot results) or by repeated measures two-way ANOVA (eg, electric field stimulation in vivo) or by t test (eg, quantitative PCR and Western blot results) where appropriate. A probability (P) level of <.05 was considered significant, and n refers to number of rats.
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